Reference : Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactiva...
Scientific journals : Article
Human health sciences : Gastroenterology & hepatology
Human health sciences : Surgery
http://hdl.handle.net/2268/97940
Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients.
English
Noterdaeme, Timothee [> > > >]
Longree, Luc [> > > >]
Bataille, Christian [Université de Liège - ULg > Département des sciences cliniques > Département des sciences cliniques]
DE ROOVER, Arnaud mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chirurgie abdominale- endocrinienne et de transplantation]
LAMPROYE, Anne mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie]
DELWAIDE, Jean mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie >]
Beguin, Yves mailto [Université de Liège - ULg > > GIGA-R : Hématologie]
Honoré, Pierre mailto [Université de Liège - ULg > Département des sciences cliniques > Chirurgicale abdominale]
DETRY, Olivier mailto [ > > ]
Jul-2011
World journal of gastroenterology : WJG
17
25
3069-72
Yes (verified by ORBi)
International
1007-9327
China
[en] Hepatitis B (HBV) reactivation induced by chemotherapy is problem encountered recently in the management of malignant diseases. Chemotherapy-induced HBV reactivation may ultimately lead to terminal acute liver failure. Liver transplantation (LT) currently remains the only definitive treatment option for such cases, but is generally denied to patients suffering from malignancy. Here, the authors describe 2 cases of cancer-free and HBV graft re-infection-free survival after LT performed for terminal liver failure arising from HBV reactivation induced by chemotherapy for advanced stage lymphoma. These 2 cases, and some other reports in the literature, may suggest that patients suffering from hematologic malignancies and terminal liver disease can be considered for LT if the prognosis of their hematologic malignancy is good.
http://hdl.handle.net/2268/97940
10.3748/wjg.v17.i25.3069

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
27882.pdfPublisher postprint551.28 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.